Bayer Q2 FY26 net income swings to profit at €219 million; net sales rise 1.2% to €10.87 billion
Reuters2026/08/04 05:33- Bayer net income swung to profit of €219 million in Q2, while net sales rose 1.2% to €10.87 billion.
- EBIT climbed to €827 million, while EBITDA before special items increased 1.9% to €2.14 billion.
- Core earnings per share from continuing operations fell 16.7% to €0.95, while net financial debt edged up 1.1% to €33.65 billion.
- Crop Science EBITDA before special items rose 30.2% to €902 million, while Pharmaceuticals slipped 3.6% to €1.06 billion.
- Currency-adjusted 2026 outlook was confirmed; net financial debt forecast was cut to €29 billion-€30 billion on a planned €3 billion Apollo investment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lazard paper warns global supply chains face O-ring-style single-point failures amid geopolitics
Andalan Perkasa Abadi says unaware of material information behind NASA share volatility
Massive Buyback Faces "Cold Reception"! U.S. Treasury Bond Purchase Plan Hits a Wall, Liquidity Tool Risks Becoming Ineffective
The US Treasury's expanded repo operations faced a record-low subscription ratio, highlighting a bottleneck in long-term bond market absorption, which may force officials to further cut issuance of the less liquid 20-year US Treasury bonds.
Crypto prices
More
